Drugs / Iron isomaltose anhydride
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03915327 | Jul 2024 → May 2028 expected | iron deficiency anemia | West China Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iron isomaltose anhydride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03915327 ↗ |
| Route | Intravenous | “receive intravenous iron isomaltose anhydride within 24 hours of the subject's inclusion.” NCT03915327 ↗ |